Loading clinical trials...
Loading clinical trials...
Individual patient expanded access requests may be considered for patients who have no other treatment options
Expanded access may be available outside of the US in countries prior to approval by the local regulatory agencies. For full details, please visit the links provided below.
Age
All ages
Sex
ALL
Healthy Volunteers
No
Last Updated
March 5, 2025
Burosumab
BIOLOGICAL
Development Division Project Management Department
CONTACT
609-919-1100kkd.clintrial.82@kyowakirin.comLead Sponsor
Kyowa Kirin Co., Ltd.
NCT03745521
NCT04842032
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT02537431